W. Nicholas Haining, BM, BCh
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name W. Nicholas Haining, BM, BCh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:33 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00069940 · Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorDana-Farber Cancer Institute · completed · Brain and Central Nervous System Tumors, Gastrointestinal Stromal Tumor, Sarcoma · study chair
- Early Ph1NCT00020670 · Vaccine Therapy in Treating Patients With Acute Lymphoblastic LeukemiaDana-Farber Cancer Institute · terminated · Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Administrative CoreP30CA006516 · NCI · DANA-FARBER CANCER INST · PI Deborah J Goff · fiscal years 2018 to 2026Named on NCT00069940, NCT00020670
- P01CA068484RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00020670
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.